The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic
Top Cited Papers
Open Access
- 4 February 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 51 (3), 506-516
- https://doi.org/10.1038/s41588-018-0331-5
Abstract
Esophageal adenocarcinoma (EAC) is a poor-prognosis cancer type with rapidly rising incidence. Understanding of the genetic events driving EAC development is limited, and there are few molecular biomarkers for prognostication or therapeutics. Using a cohort of 551 genomically characterized EACs with matched RNA sequencing data, we discovered 77 EAC driver genes and 21 noncoding driver elements. We identified a mean of 4.4 driver events per tumor, which were derived more commonly from mutations than copy number alterations, and compared the prevelence of these mutations to the exome-wide mutational excess calculated using non-synonymous to synonymous mutation ratios (dN/dS). We observed mutual exclusivity or co-occurrence of events within and between several dysregulated EAC pathways, a result suggestive of strong functional relationships. Indicators of poor prognosis (SMAD4 and GATA4) were verified in independent cohorts with significant predictive value. Over 50% of EACs contained sensitizing events for CDK4 and CDK6 inhibitors, which were highly correlated with clinically relevant sensitivity in a panel of EAC cell lines and organoids.Keywords
This publication has 57 references indexed in Scilit:
- The mutational landscape of phosphorylation signaling in cancerScientific Reports, 2013
- Emerging landscape of oncogenic signatures across human cancersNature Genetics, 2013
- Pan-cancer patterns of somatic copy number alterationNature Genetics, 2013
- OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genesBioinformatics, 2013
- Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexityNature Genetics, 2013
- Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and OncogenesisCancer Research, 2012
- Functional impact bias reveals cancer driversNucleic Acids Research, 2012
- Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal AdenocarcinomaClinical Cancer Research, 2011
- PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitroBreast Cancer Research, 2009
- A census of human cancer genesNature Reviews Cancer, 2004